Key result
Rapid deployment aortic valve replacement with the Edwards INTUITY valve system demonstrated a 5-year survival rate of 85.7% for isolated AVR and 98.2% freedom from valve-related death.
Why the study?
Does rapid deployment aortic valve replacement with the Edwards INTUITY valve system provide long-term safety and efficacy in patients with aortic valve stenosis?
Does rapid deployment aortic valve replacement with the Edwards INTUITY valve system provide long-term safety and efficacy in patients with aortic valve stenosis?
Rapid deployment aortic valve replacement with the Edwards INTUITY valve system demonstrates acceptable long-term safety and excellent haemodynamic performance up to 5 years.
Answers are grounded in this paper and cite their sources.
Supports long-term safety of rapid deployment valves in aortic stenosis; leaves open.
OBJECTIVES: Rapid deployment aortic valve replacement (AVR) has been developed to facilitate minimally invasive approaches for cardiac surgery and shorten procedural times. TRITON is a prospectively designed study to assess safety and efficacy of rapid deployment AVR with Edwards INTUITY valve system. This report presents the 5-year outcomes of the TRITON trial. METHODS: A total of 295 patients with aortic valve stenosis were enrolled in the TRITON trial and 287 patients received the study valve. Procedural, early (≤30 days) and late (>30 days) outcomes were collected. Valve haemodynamic performance was evaluated at specified time points by an independent Echocardiography Core Laboratory and clinical events adjudicated by an independent Clinical Events Committee. RESULTS: Mean age was 75.3 ± 6.7 years. A total of 158 patients underwent isolated AVR and 129 patients underwent AVR with concomitant procedures. The 5-year survival rates were 85.7 ± 3.4% and 75.2 ± 4.9% for isolated AVR and concomitant AVR, respectively. Overall, freedom from valve-related death at 5 years was 98.2 ± 0.8%. At 5 years, the valve effective orifice area was 1.6 ± 0.3 cm 2 , mean gradient was 10.5 ± 5.4 mmHg and peak gradient was 18.9 ± 9.3 mmHg. CONCLUSIONS: The 5-year outcomes of the TRITON trial demonstrate acceptable long-term safety and excellent haemodynamic performance of rapid deployment AVR with the Edwards INTUITY valve system. CLINICALTRIALS.GOV: NCT01445171.
No takes yet. Share an insight, caveat, or question.
Laufer et al. (2017) studied Aortic valve stenosis (n=295). Rapid deployment aortic valve replacement with Edwards INTUITY valve system was evaluated on 5-year survival rate (isolated AVR). Rapid deployment aortic valve replacement with the Edwards INTUITY valve system demonstrated a 5-year survival rate of 85.7% for isolated AVR and 98.2% freedom from valve-related death.
Synapse has enriched 10 related papers. Consider them for comparative context: